Ikeda, Japan

Hatsuo Aoki

This inventor holds 17 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1978-1989.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 5

Forward Citations = 68(Granted Patents)


Location History:

  • Ikeda, JA (1978)
  • Ikeda, JP (1978 - 1989)

Company Filing History:


Years Active: 1978-1989

Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovations of Hatsuo Aoki

Introduction

Hatsuo Aoki is a prominent inventor based in Ikeda, Japan. He has made significant contributions to the field of pharmacology, particularly through his innovative work on peptides. With a total of 17 patents to his name, Aoki has established himself as a key figure in pharmaceutical research and development.

Latest Patents

Among his latest patents, Aoki has developed novel peptides with pharmacological activity. One of his notable inventions is a peptide, process for preparation thereof and use thereof, which relates to peptides of the formula: ##STR1## wherein R.sup.1 is hydrogen. Additionally, he has created another peptide, process for preparation thereof and use thereof, which focuses on peptides of enhanced pharmacological activity, represented by the formula: ##STR1## wherein R.sup.1 is hydroxyalkanoyl. These innovations highlight his commitment to advancing medical science.

Career Highlights

Aoki is currently associated with Fujisawa Pharmaceutical Company, Ltd., where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the company's portfolio but has also had a lasting impact on the industry as a whole.

Collaborations

Throughout his career, Aoki has collaborated with esteemed colleagues such as Hiroshi Imanaka and Masanobu Kohsaka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Hatsuo Aoki's contributions to the field of pharmacology through his innovative peptide research and development are commendable. His work continues to influence the pharmaceutical industry and improve therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…